|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61P 31/00 | (2006.01) |
| (11) | Number of the document | 1425028 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02736912.3 |
| Date of filing the European patent application | 2002-05-16 | |
| (97) | Date of publication of the European application | 2004-06-09 |
| (45) | Date of publication and mention of the grant of the patent | 2009-12-16 |
| (46) | Date of publication of the claims translation | 2010-01-25 |
| (86) | Number | PCT/US2002/015556 |
| Date | 2002-05-16 |
| (87) | Number | WO 2002/092008 |
| Date | 2002-11-21 |
| (30) | Number | Date | Country code |
| 291463 P | 2001-05-16 | US |
| (72) |
DINARELLO, Charles, A., US
FANTUZZI, Giamila, US
KIM, Soo-Hyun, US
REZNIKOV, Leonid, US
RUBINSTEIN, Menachem, IL
NOVICK, Daniela, IL
SCHWARTSBURD, Boris, IL
|
| (73) |
Yeda Research And Development Co. Ltd.,
Weizmann Institute of Science P.O. Box 95, 76100 Rehovot,
IL
|
| (74) |
Marija LENKUTIENĖ,
Patentinių paslaugų centras, UAB, Jono Basanavičiaus g. 11/1, LT-03108 Vilnius,
LT
|
| (54) | IL-18 inhibitorių panaudojimas kraujo užkrėtimo gydymui arba prevencijai |
| USE OF IL-18 INHIBITORS FOR THE TREATEMENT OR PREVENTION OF SEPSIS |
| Payment date | Validity (years) | Amount | |
| 2021-04-21 | 347.00 EUR |